TRASTUZUMAB ðŸĨ āđ€āļ§āđ‡āļšāļžāļ™āļąāļ™āļ­āļąāļ™āļ”āļąāļš1

āđāļšāļĢāļ™āļ”āđŒ: TRASTUZUMAB

TRASTUZUMAB   TRASTUZUMAB trastuzumab, sold under the brand name herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer āđ€āļāļĄāļŠāļĨāđ‡āļ­āļ• it is

TRASTUZUMAB herceptin (trastuzumab) herceptin was the first her2 targeted therapy for breast cancer it is a monoclonal antibody that binds to her2 receptors present on āļĢāļ°āļšāļšāļāļēāļāļ–āļ­āļ™āđ€āļĢāđ‡āļ§ trastuzumab āļ–āļ­āļ™āđ„āļĄāđˆāļ­āļąāđ‰āļ™ for women with her2 positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments treatment with trastuzumab āļāļēāļāļ–āļ­āļ™āļ­āļąāļ•āđ‚āļ™āļĄāļąāļ•āļī trastuzumab āđ€āļāļĄāļŠāļĨāđ‡āļ­āļ•

TRASTUZUMAB comment trastuzumab is a humanized igg1Κ monoclonal antibody targeting her2 annotated peptide sequences for this antibody are available from its imgt mab db āđ€āļ§āđ‡āļšāļŠāļĨāđ‡āļ­āļ•āļ­āļ­āļ™āđ„āļĨāļ™āđŒ trastuzumab āđ€āļĨāđˆāļ™āļŠāļ™āļļāļ nhs medicines information on trastuzumab – what it's used for, side effects, dosage and who can have it trastuzumab āļāļēāļāļ–āļ­āļ™āļ­āļąāļ•āđ‚āļ™āļĄāļąāļ•āļī

āļŋ1,190
āļŋ2,164 -45%
āļˆāļģāļ™āļ§āļ™
āļˆāļģāļŦāļ™āđˆāļēāļĒāđ‚āļ”āļĒ


Date Modified: 2024-10-13 00:42:33